March 10, 2025
A national multi-site clinical trial, co-led by researchers at the UNC School of Medicine, has found that therapeutic hypothermia may be harming preterm infants recovering from a specific type of brain injury.
October 15, 2024
U.S. Department of Defense awarded $2.8 million to UNC Institute for Trauma Recovery researchers led by Samuel McLean, MD, to test the safety and efficacy of BXCL501 – sublingual dexmedetomidine created by BioXcel Therapautics for treating acute stress reaction symptoms and preventing posttraumatic stress.
September 25, 2024
In May 2022, Yael Shiloh-Malawsky, MD, a neurologist at the UNC School of Medicine, met two new patients combatting a rare and fatal neurodegenerative disorder called Batten disease. With help from UNC, the twin girls were able to get personalized treatment from bench to bedside in record time.
July 24, 2024
For patients with atrial fibrillation, using a wearable device can lead to higher rates of anxiety about their Afib symptoms and treatment, doctor visits, and use of informal healthcare resources, according to a new study from UNC School of Medicine researchers led by Lindsey Rosman, PhD.
June 25, 2024
Christian Hendershot, PhD, associate professor of psychiatry and director of the Clinical and Translational Addiction Research Program at the UNC School of Medicine, presented early findings from the first completed randomized controlled trial of semaglutide for reducing alcohol consumption in heavy drinkers.
April 5, 2024
John P. Vavalle, MD, MHS, FACC, and Matthew A. Cavender, MD, MPH, FACC, interventional cardiologists and their collaborative team in the Structural Heart Disease Program at UNC, have performed their first transcatheter tricuspid valve replacement in the clinical setting, a revolutionary treatment for patients living with a common type of heart valve disease.
January 12, 2024
The Rare Diseases Network podcast featured work from the Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) and a paper on primary ciliary dyskinesia published by researchers in the UNC Department of Otolaryngology/Head and Neck Surgery. Senior author is Adam Kimple, MD, PhD.
January 9, 2024
David Y. Hwang, MD, professor of neurology and division chief of neurocritical care, is co-principal investigator along with colleagues at Duke for a new eastern North Carolina and southern Virginia stroke clinical trial coordinating center.
November 7, 2023
UNC Health is the only academic healthcare system in North Carolina and the South participating in the randomized trial, which aims to assess the safety and efficacy of a combination immunotherapy for newly diagnosed glioblastoma patients.
October 18, 2023
The $5-million initiative, led by the UNC School of Medicine and funded through the U.S. Department of Defense, will test the efficacy of an intervention developed at the Walter Reed Army Institute of Research originally designed to help service members who experience acute stress reactions during military operations. Sam McLean, MD, MPH, professor of psychiatry and emergency medicine, is the principal investigator.
September 12, 2023
A phase 2 study, led by Thomas W. Ferkol, MD, at the UNC School of Medicine, demonstrates safety and efficacy of idrevloride with hypertonic saline for treatment of primary ciliary dyskinesia, a rare genetic disorder that can lead to permanent lung damage.
July 6, 2023
Washington, N.C man with squamous cell carcinoma of the tongue experiences positive life-changing results after participating in an induction therapy clinical trial at the UNC School of Medicine.